期刊文献+

雌性大鼠细胞色素P4503A酶诱导模型建立与验证 被引量:4

Establishment and Verification of Cytochrome P450 3A Enzyme Induction Model in Female Rats
原文传递
导出
摘要 目的建立雌性大鼠CYP3A酶诱导模型,用于CYP3A酶介导的药物-药物相互作用研究。方法 标准喂养的雌性SD大鼠18只随机分为两组,一组为空白对照组(3只),一组为实验组(15只分为5组)。实验组分别用20、50、80、100、150 mg·kg-1·d-1地塞米松连续灌胃3 d诱导CYP3A酶,灌胃3 d后的24 h,分别取两组大鼠的肝组织制备肝微粒体,以睾酮为探针底物,测定CYP3A4酶活性。结果 空白肝微粒体中睾酮代谢率为31.68%,地塞米松诱导组中睾酮代谢率为40.64%、61.36%、82.44%、85.8%、83.36%,经80 mg·kg-1·d-1地塞米松诱导后大鼠睾酮代谢率提高达160.23%。结论以地塞米松80 mg·kg-1·d-1的剂量诱导SD大鼠能够显著增加大鼠肝内CYP3A酶的活性,可用于研究CYP3A酶介导的药物-药物相互作用。 OBJECTIVE To establish a female rat CYP3A induction model which is used for studying CYP3A-mediated drug-drug interactions. METHODS Female SD rats which were fed with standard diet were randomly divided into two groups, one was the control group, and the other one was the experimental group. The rats in the experimental group were administered respectively 20, 50, 80, 100, and 150 mg. kg^-1 . d^-1 dexamethasone by gavage for 3 d to induce CYP3A enzymes. 24 h after 3 d, liver tissues were taken from both groups of rats and rat liver mierosomes were prepared. CYP3A4 activity was determined with testosterone as the probe substrate. RESULTS Testosterone metabolic rate was 31.68% in blank liver microsomes, and were 40. 64% , 61.36% , 82. 44% , 85.8% , and 83.36% in dexamethasone-induction group. Testosterone metabolic rate was improved by up to 160. 23% after dexam- ethasone induction at 80 mg . kg^-1 . d^-1 in female rats. CONCLUSION Dexamethasone induction at 80 mg . kg^-1 . d^-1 can significantly increase liver CYP3A enzyme activity in female SD rats, and the model can be used to study CYP3A-mediated drug-drug interactions.
出处 《中国药学杂志》 CAS CSCD 北大核心 2013年第12期995-999,共5页 Chinese Pharmaceutical Journal
基金 杭州市科技局指导项目 常州四药临床药学基金(CS20109010)
关键词 雌性大鼠 CYP3A 药物代谢模型 female SD rat CYP3 A4 metabolism kinetics model
  • 相关文献

参考文献3

二级参考文献62

  • 1王晓晖.高压液相色谱法测定人血浆中表阿霉素的含量[J].抗感染药学,2005,2(2):89-90. 被引量:2
  • 2张阳德,丁诚,张宗久,张浩伟,齐贵新,潘一峰.优化工艺制备表阿霉素α-聚氰基丙烯酸正丁酯纳米粒[J].中华实验外科杂志,2006,23(10):1191-1193. 被引量:8
  • 3黄桂华,祝侠丽,张娜,张丙杰.洛莫司汀热敏脂质体的制备及体外抗肿瘤活性研究[J].中国药学杂志,2007,42(12):914-918. 被引量:8
  • 4Nelson DR, Kamataki T, Waxman D J, et al. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature[J]. DNA Cell Biol, 1993, 12( 1 ) : 1.
  • 5Imaoka ST, Yamada T, Hiroi K, et al. Muitiple forms of human P450 expressed in saccharomyces cerevisiae, systematic characterization and comparison with those of the rat[J]. Biochem Pharmacol, 1996,51 (8):1 041.
  • 6Yamano S, Tatsuno J, Gonzale FJ. The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes[J]. Biochemistry, 1990,29(5):1 322.
  • 7Caroline AL, Sue HK, Thomas AK, et al. CYP3A4 expressed by insect cells infected with a recombinant baculovirus bontaining both CYP3A4 and human NADPH-cytochrome P450 reductase is catalytically similar to human liver microsomal CYP3A4[J]. Archives of Biochemistry and Biophysics, 1995,319 (1):157.
  • 8Arthur GR, William MA. Energetics of heterotropic cooperativity between a-naphthoflavone and testosterone binding to CYP3A4[J]. Archives of Biochemistry and Biophysics, 2007,463(1) : 89.
  • 9Jessica LF, David MP, Barbara JR, et al. A novel testosterone 6b-hydroxylase activity assay for the study of CYP3A-mediated metabolism, inhibition, and induction in vitro[J]. J Pharmacol Toxicol Methods, 2002, 46 (2) : 117.
  • 10Rile RJ, Howbrook D. In vitro analysis of the activity of the major human hepatic CYP enzyme (CYP3A4) using [N-methyl-14C]-erythromycin[J]. J Pharmacol Toxicol Methods, 1997,38(4) : 189.

共引文献22

同被引文献47

  • 1张慧锋,王月鹏,李妍.细胞色素P450的研究进展[J].吉林医药学院学报,2005,26(3):174-177. 被引量:24
  • 2黄继汉,黄晓晖,陈志扬,郑青山,孙瑞元.药理试验中动物间和动物与人体间的等效剂量换算[J].中国临床药理学与治疗学,2004,9(9):1069-1072. 被引量:1283
  • 3王青秀,吴纯启,施畅,廖明阳.地塞米松对大鼠肝脏微粒体细胞色素P-450的诱导效应[J].中国新药杂志,2005,14(6):705-708. 被引量:2
  • 4王莉娥,杨明学,谢广云.一种用聚乙二醇制备微粒体的方法[J].生物化学与生物物理进展,1995,22(5):462-464. 被引量:19
  • 5Xia ZL, Wang ML, Zou SL, et al. Different effects of dihydropyri- dine calcium channel antagonists on CYP3A4 enzyme of human liver microsomes[ J ]. Eur J Drug Metab Pharmacokinet, 2012,37 (3): 211-216.
  • 6Liu A, Yang J, Zhao X,et al. Induction of P450 3A1/2 and 2C6 by gemfibrozil in Sprague-Dawley rats [ J ]. Pharmacol Rep, 2011,63 (1) :157-164.
  • 7Kanazu T, Yamaguchi Y, Okamura N, et al. Model for the drug-drug interaction responsible for CYP3A enzyme inhibition. Ⅱ : establish- ment and evaluation of dexamethasone-pretreated female rats[J]. Xe- nobiotica, 2004,34(5) :403-413.
  • 8Nelson D R, Koymans L, Kamataki T, Stegeman J J, Feyereisen R, Waxman D J, Waterman M R, Gotoh O, Coon M J, Estabrook R W, Gunsalus I C, Nebert D W. P450 super family: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 1996, 6(1): 1-42.
  • 9Wrighton S A, Schuctz E C, Thummel K E, Shcn D D, Korzekwa K R, Warkins P B. The human CYP3A subfamily: practical considerations. Drug Metabolism Reviews, 2000, 32 (3/4): 339-361.
  • 10Jirimutu, Wang Z, Ding G H, Chen G L, Sun Y M, Sun Z H, Zhang H P, Wang L, Hasi S R, Zhang Y, Li J M, Shi Y X, Xu Z, He C, Yu S, Li S, Zhang W B, Batmunkh M, Ts B, Narenbam, Unierhu, Bat-Ireedui S, Gao H W, Baysgalan B, Li Q, Jia Z L, Turigenbayila, Subudenggerile, Narenmanduhu, Wang Z X, Wang J, Pan L, Chen Y C, Ganerdene Y, Dabxilt, Erdemt, Altansha, Altansukh, Liu T, Can M H, Aruuntsever, Bayart, Hosblig, He F, Zhati A, Zheng G Y, Qiu F, Sun Z, Zhan L L, 7_,hao W J, Liu B H, Li C, Chen Y Q, Tang X Y, Guo C Y, Liu W, Ming L, Temuulen, Cuil A, Li Y, Gao J H, Li J, Wurentandi, Niu S, Sun T, Zhai Z X, Zhang M, Chen C, Baldan T, Bayaer T, Li Y X, Meng H. Genome sequences of wild and domestic Bactrian camels. Nature Communications, 2012, 3:1202.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部